Publications:33
An-Li Wang, PhD
About Me
Language
Position
About Me
Language
Position
Education
PhD, University of Oxford
Postdoc, University of Pennsylvania
Research
When ERPs are elicited by pairs or trains of stimuli delivered at short inter‐stimulus intervals (ISIs), the magnitude of the ERP elicited by the repeated stimuli is markedly reduced, a phenomenon known as response decrement. While the interval between two consecutive stimuli becomes longer, the reduced response is recovered. Thus, this phenomenon has been traditionally interpreted in terms of neural refractoriness of generators of ERPs (“neural refractoriness hypothesis”). A series of my ERP studies, however, challenge this neural refractoriness hypothesis by manipulating the preceding events of the eliciting stimulus.
Locations
Publications
Selected Publications
- Repetitive transcranial magnetic stimulation for the treatment of suicidality in opioid use disorder: A pilot feasibility randomized controlled trial. Victor M. Tang, Bernard Le Foll, Zafiris J. Daskalakis, An Li Wang, Leslie Buckley, Daniel M. Blumberger, Daphne Voineskos. European Psychiatry
- Contextual processing and its alterations in patients with addictive disorders. Igor Elman, Dan Ariely, Marina Tsoy-Podosenin, Elena Verbitskaya, Valentina Wahlgren, An Li Wang, Edwin Zvartau, David Borsook, Evgeny Krupitsky. Addiction Neuroscience
- Effects of emotional arousal on the neural impact and behavioral efficacy of cigarette graphic warning labels. Zhenhao Shi, An Li Wang, Victoria P. Fairchild, Catherine A. Aronowitz, James H. Padley, Kevin G. Lynch, James Loughead, Daniel D. Langleben. Addiction
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Wang has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Wang has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.